These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9598832)

  • 1. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
    Llorente-Cortés V; Martínez-González J; Badimon L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition.
    Llorente-Cortés V; Martínez-González J; Badimon L
    Atherosclerosis; 1999 Jun; 144(2):335-42. PubMed ID: 10407494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.
    Llorente-Cortés V; Martínez-González J; Badimon L
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1572-9. PubMed ID: 10845874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
    Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells.
    Llorente-Cortés V; Otero-Viñas M; Camino-López S; Llampayas O; Badimon L
    Circulation; 2004 Jul; 110(4):452-9. PubMed ID: 15238452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
    Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
    Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin enhanced sodium nitroprusside-induced apoptosis of smooth muscle cells. An involvement of geranylgeraniol.
    Fujita H; Shimotsuura S; Yanagisawa A; Morita I; Murota S; Ishikawa K
    Atherosclerosis; 2000 Feb; 148(2):309-15. PubMed ID: 10657567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition.
    Padró T; Lugano R; García-Arguinzonis M; Badimon L
    PLoS One; 2012; 7(6):e38935. PubMed ID: 22719992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation.
    Martínez-González J; Raposo B; Rodríguez C; Badimon L
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):804-9. PubMed ID: 11348878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages.
    Llorente-Cortés V; Royo T; Juan-Babot O; Badimon L
    J Lipid Res; 2007 Oct; 48(10):2133-40. PubMed ID: 17620659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors reduce acetyl LDL endocytosis in mouse peritoneal macrophages.
    Bernini F; Scurati N; Bonfadini G; Fumagalli R
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1352-8. PubMed ID: 7670949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of heparan sulfate proteoglycans on aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts.
    Llorente-Cortés V; Otero-Viñas M; Badimon L
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1905-11. PubMed ID: 12426223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism.
    Llorente-Cortés V; Otero-Viñas M; Sánchez S; Rodríguez C; Badimon L
    Circulation; 2002 Dec; 106(24):3104-10. PubMed ID: 12473559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
    Peffley DM; Gayen AK; Morand OH
    Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R
    Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
    Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
    Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin.
    Martin-Ventura JL; Blanco-Colio LM; Aparicio C; Ortega L; Esbrit P; Egido J
    Atherosclerosis; 2008 Jun; 198(2):264-71. PubMed ID: 18378243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.